Offer - Urjas Oil for just ₹ 1 X
Utergin 0.125 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Post Delivery Bleeding.
Medical history of the patient along with age and gender determines the dosage of Utergin 0.125 Tablet. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Utergin 0.125 Tablet include Headache, Abdominal Pain, Hypertension. While these are the most often observed Utergin 0.125 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Utergin 0.125 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Utergin 0.125 Tablet's effect during pregnancy is Unknown and Unknown while nursing. Further, the section on Utergin 0.125 Tablet related warnings talks about Utergin 0.125 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like High Blood Pressure must refrain from the use of Utergin 0.125 Tablet since this can cause severe adverse effects. Other contraindications of Utergin 0.125 Tablet have been discussed in the sections ahead.
Additionally, Utergin 0.125 Tablet may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Utergin 0.125 Tablet is safe while driving, and is addiction.
Utergin 0.125 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Utergin 0.125 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Utergin in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Utergin 0.125 Tablet safe during breastfeeding?
Information about safety of Utergin for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Utergin 0.125 Tablet on the Kidneys?
Utergin has very mild side effects on the kidneys.
What is the effect of Utergin 0.125 Tablet on the Liver?
Utergin can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Utergin 0.125 Tablet on the Heart?
Effects of Utergin on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Utergin 0.125 Tablet unless your doctor advises you to do so -
Is this Utergin 0.125 Tablet habit forming or addictive?
No, you will not get addicted to Utergin 0.125 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Utergin 0.125 Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Utergin 0.125 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Utergin 0.125 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Utergin 0.125 Tablet
Due to the absence of research, it is difficult to say how Utergin 0.125 Tablet and food will interact.
Interaction between Alcohol and Utergin 0.125 Tablet
Information about the interaction of Utergin 0.125 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839